LYEL
Lyell Immunopharma Inc
9.10$
-2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.41 | 0.40 | 0.40 | 0.38 | – | 0.38 | – | 0.21 | – | 0.14 | 0.11 | – | – | |
| -0.40 | -0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.11 | 0.00 | -0.10 | |
| 3.18 | 3.29 | 3.40 | 3.15 | 3.08 | 3.65 | 2.94 | 2.36 | 1.54 | 3.05 | 1.67 | 1.69 | 6.70 | |
| 1.23 | 1.04 | 1.06 | 0.96 | 0.92 | 1.09 | 0.95 | 0.66 | 0.59 | 0.62 | 0.44 | 0.41 | 1.73 | |
| 4.42 | 4.33 | 4.37 | 4.04 | 3.94 | 15.09 | 3.89 | 3.19 | 2.04 | 3.59 | 2.00 | 2.03 | 8.12 | |
| -4.82 | -4.73 | -4.37 | -4.04 | -3.94 | -15.09 | -3.89 | -3.19 | -2.04 | -3.59 | -2.11 | -2.03 | -8.22 | |
| -4.05 | -4.18 | -4.77 | -3.59 | -3.48 | -14.40 | -3.54 | -2.89 | -2.13 | -8.23 | -1.10 | -1.92 | -10.64 | |
| -0.53 | 0.40 | 0.39 | – | – | – | – | – | – | – | – | – | – | |
| -4.05 | -4.18 | -4.77 | -3.59 | -3.48 | -14.40 | -3.54 | -2.89 | -2.13 | -8.23 | -1.10 | -1.92 | -10.64 | |
| -3.64 | -3.78 | -4.38 | -3.20 | -3.11 | -4.33 | -3.30 | -2.88 | -1.99 | -8.09 | -1.00 | -1.82 | -10.23 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.